PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Electronic tattoo gauges mental strain

2025-05-29
(Press-News.org) Researchers gave participants face tattoos that can track when their brain is working too hard. Published May 29 in the Cell Press journal Device, the study introduces a non-permanent wireless forehead e-tattoo that decodes brainwaves to measure mental strain without bulky headgear. This technology may help track the mental workload of workers like air traffic controllers and truck drivers, whose lapses in focus can have serious consequences.

"Technology is developing faster than human evolution. Our brain capacity cannot keep up and can easily get overloaded," says Nanshu Lu, the study's author, from the University of Texas at Austin (UT Austin). “There is an optimal mental workload for optimal performance, which differs from person to person.”

Humans perform best in a cognitive Goldilocks zone, neither overwhelmed nor bored. Finding that balance is key to optimal performance. Current mental workload assessment relies on the NASA Task Load Index, a lengthy and subjective survey participants complete after performing tasks.

The e-tattoo offers an objective alternative by analyzing electrical activity from the brain and eye movement, in processes known as electroencephalography (EEG) and electrooculography (EOG). Unlike EEG caps that are bulky with dangling wires and lathered with squishy gel, the wireless e-tattoo consists of a lightweight battery pack and paper-thin, sticker-like sensors. These sensors feature wavy loops and coils, a design that allows them to stretch and conform seamlessly to the skin for comfort and clear signals.

“What’s surprising is those caps, while having more sensors for different regions of the brain, never get a perfect signal because everyone’s head shape is different,” says Lu. “We measure participants’ facial features to manufacture personalized e-tattoos to ensure that the sensors are always in the right location and receiving signals.”

The researchers tested the e-tattoo on six participants who completed a memory challenge that increased in difficulty. As mental load rose, participants showed higher activity in theta and delta brainwaves, signaling increased cognitive demand, while alpha and beta activity decreased, indicating mental fatigue. The results suggest that the device can detect when the brain is struggling.

The device didn’t stop at detection. It could also predict mental strain. The researchers trained a computer model to estimate mental workload based on signals from the e-tattoo, successfully distinguishing between different levels of mental workload. The results show that the device can potentially predict mental fatigue.

Cost is another advantage. Traditional EEG equipment can exceed $15,000, while the e-tattoo’s chips and battery pack costs $200, and disposable sensors are about $20 each. “Being low cost makes the device accessible,” says author Luis Sentis from UT Austin. “One of my wishes is to turn the e-tattoo into a product we can wear at home.”

While the e-tattoo only works on hairless skin, the researchers are working to combine it with ink-based sensors that work on hair. This will allow for full head coverage and more comprehensive brain monitoring. As robots and new technology increasingly enter workplaces and homes, the team hopes this technology will enhance understanding of human-machine interaction.

“We’ve long monitored workers’ physical health, tracking injuries and muscle strain,” says Sentis. “Now we have the ability to monitor mental strain, which hasn’t been tracked. This could fundamentally change how organizations ensure the overall well-being of their workforce.”

###

Device, Huh et al. “A Wireless Forehead E-tattoo for Mental Workload Estimation” http://cell.com/device/fulltext/S2666-9986(25)00094-8 DOI: 10.1016/j.device.2025.100781

Device (@Device_CP), is a physical science journal from Cell Press along with Chem, Joule, and Matter. Device aims to be the breakthrough journal to support device- and application-oriented research from all disciplines, including applied physics, applied materials, nanotechnology, robotics, energy research, chemistry, and biotechnology, under a single title that focuses on the integration of these diverse disciplines in the creation of the cutting-edge technology of tomorrow. Visit http://www.cell.com/device/home. To receive Cell Press media alerts, contact press@cell.com.

END



ELSE PRESS RELEASES FROM THIS DATE:

Public awareness of the association between alcohol and cancer in the U.S.

2025-05-29
About The Study: The findings of this study that fewer than half of U.S. adults are aware and about one-fifth are unsure of their awareness of the association between alcohol and cancer emphasize the need to implement the recently updated Surgeon General’s recommendation to reduce the alcohol-related cancer burden in the U.S. Corresponding Author: To contact the corresponding author, Sanjay Shete, PhD, email sshete@mdanderson.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoncol.2025.1146) Editor’s Note: Please ...

Acupuncture for nocturia in survivors of prostate cancer

2025-05-29
About The Study: In this pilot trial, acupuncture produced greater reductions in nocturia (waking up 1 or more times to urinate) relative to usual care in survivors of prostate cancer. The nocturia reduction was comparable to other treatments, such as desmopressin, α-blockers, and antimuscarinic medications; however, acupuncture was associated with fewer adverse events. Nocturia affects more than half of survivors of prostate cancer. Corresponding Author: To contact the corresponding author, Kevin T. Liou, MD, email liouk@mskcc.org. To access the embargoed ...

New study finds recovery is still possible for critically endangered Hawaiian honeycreeper with urgent intervention

2025-05-29
CONTACT:           San Diego Zoo Wildlife Alliance Public Relations 619-685-3291  publicrelations@sdzwa.org sdzwa.org PHOTOS AND VIDEO: https://sandiegozoo.box.com/s/uzfr25f5xzcgxyj0tgww5ob6nvafuyng NEWS RELEASE New Study Finds Recovery Is Still Possible for Critically Endangered Hawaiian Honeycreeper With Urgent Intervention Latest Genomic Research Offers a Unique Lens for Understanding the Extinction Crisis in Hawai‘i SAN DIEGO (May 29, 2025) – A new scientific study, led by San Diego Zoo ...

All-in-one model reconstructs complex liver architecture

2025-05-29
To the point: New tissue-derived organoid model: A next-generation organoid model, composed of three liver cell types – adult hepatocytes, cholangiocytes, and liver mesenchymal cells – reconstructs the liver periportal region. Organoid functionality: The complex organoids, or assembloids, are functional, consistently draining bile from the bile canaliculi into the bile duct as in the real liver due to their accurate tissue architecture recapitulation. Liver disease modelling: This liver model reconstructs the liver periportal region architecture, is able to model aspects of cholestatic liver injury and biliary ...

Most Americans unaware of cancer risks associated with drinking alcohol

2025-05-29
Despite established connections, study finds almost 60% of U.S. adults are unaware or uncertain of the link between alcohol and cancer  An estimated 75,000 cancer cases are associated with alcohol annually in the U.S.  Researchers suggest implementing new Surgeon General recommendations could be an effective approach to reducing future cancer rates  HOUSTON, MAY 29, 2025 ― Alcohol is a leading preventable cause of cancer, but public awareness of the connection remains strikingly low in the U.S., with ...

New insights into bladder cancer treatment could help improve immunotherapies

2025-05-29
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer. Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) and is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly. BCG is a weakened strain of the bacterium Mycobacterium bovis, which is ...

HIV discovery could open door to long-sought cure

2025-05-29
University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly it replicates, and how easily or stubbornly it can reawaken from hiding. These insights bring researchers closer to finding ways to flush out the dormant virus and eliminate it for good. Thanks to remarkable progress in HIV treatment, the virus can often be suppressed to undetectable levels in the blood, eliminating most disease symptoms, and preventing transmission to others. But HIV never truly ...

The purrfect gene

2025-05-29
Kyoto, Japan -- Whether you are lucky enough to have a cat companion or must merely live this experience vicariously through cat videos, Felis catus is a familiar and comforting presence in our daily lives. Unlike most other feline species, cats exhibit sociality, can live in groups, and communicate both with other cats and humans, which is why they have been humans' trusted accomplices for millennia. Despite this intimacy, there is still much that we don't know about our feline friends. Numerous behavioral studies have been conducted on other mammal species, but relatively few on cats. In part to fill this gap, a team of researchers at ...

Researchers find promise in a new peptide drug to combat a deadly brain cancer

2025-05-29
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer. In a study published in May in Cell Death and Disease, researchers identified a previously unknown trait of cancer cells that shows promise for therapeutic intervention. The group outlined the mechanism of action and effectiveness of the experimental drug known as JM2, revealing ...

Two WCM scientists receive inaugural Pershing Square Foundation Ovarian Cancer Challenge Grant

2025-05-29
(New York, May 29, 2025) – Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology, both from Weill Cornell Medicine, have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant. The challenge grant provides $750,000 in funding over three years to support innovative research into ovarian cancer ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] Electronic tattoo gauges mental strain